- Citations, last 5 years
- 11
- Works, last 5 years
- 15
- h-index
- 16
- Scientists listed
- 0
- Grants since 2016
- 248
Grants received
2022 · research · R01
Genetic and molecular mechanisms of Nf1-dependent neuronal regulation of metabolism
Seth M Tomchik · Scripps (United States) · funded by National Institutes of Health
2021–2026 · research · R01
Molecular basis of activation of the orphan nuclear receptor Nurr1
Douglas Kojetin · Scripps (United States) · funded by National Institutes of Health
2021–2022 · fellowship · F31
Elucidating the molecular mechanisms underlying ligand-dependent REV-ERB activity in Th17 cells
Sarah Mosure · Scripps (United States) · funded by National Institutes of Health
2021–2022 · grant · S10
Sciex 6500+ QTrap Mass Spectrometer
Michael Darin Cameron · Scripps (United States) · funded by National Institutes of Health
2021–2022 · grant · S10
Tandem Multi-modal Plate Readers for a High Throughput Screening platform
Louis Daniel Scampavia · Scripps (United States) · funded by National Institutes of Health
2021–2022 · cooperative agreement · U01
Nuclear Receptor Networks in Mucosal Immune Regulation
Matthew Eugene Pipkin · Scripps (United States) · funded by National Institutes of Health
2021–2022 · research · R01
TRP channel regulation of feeding behavior in Drosophila
William W Ja · Scripps (United States) · funded by National Institutes of Health
2021–2022 · fellowship · F31
The role of bidirectional transport of lysosome-related organelles in learning and memorystorage
Kerriann Badal · Scripps (United States) · funded by National Institutes of Health
2021–2022 · research · R21
Delineating contributions of PI3K signaling to neurodevelopmental consequences of Pten haploinsufficiency
Damon Theron Page · Scripps (United States) · funded by National Institutes of Health
2021 · research · R56
Host factors regulating HIV latency and reactivation
Susana T Valente · Scripps (United States) · funded by National Institutes of Health
2021–2022 · research · R21
T-cell engaging bispecific antibodies designed for proteolytic activation in the tumor microenvironment
Christoph Rader · Scripps (United States) · funded by National Institutes of Health
2021–2022 · research · R61
Drug Discovery for First-In-Class Myosin 10 Inhibitors as a Novel Target for Glioblastoma
Theodore M Kamenecka · Scripps (United States) · funded by National Institutes of Health
2021–2022 · research · R35
Bridging the Glycome and Proteome with Chemical Biology
Mia L Huang · Scripps (United States) · funded by National Institutes of Health
2021–2022 · research · R35
Molecular Mechanisms of Cell Adhesion
Tina Izard · Scripps (United States) · funded by National Institutes of Health
2021–2022 · research · R21
Validation and characterization of Tat inhibitors identified through HTS
Susana T Valente · Scripps (United States) · funded by National Institutes of Health
2021–2022 · research · R01
Nuclear Receptor Control of T Cell Function in Discrete Intestinal Microenvironments
Mark Scott Sundrud · Scripps (United States) · funded by National Institutes of Health
2021–2022 · research · R56
Illuminating Galectin-3 Interactions to Disrupt Hepatic Fibrosis
Mia L Huang · Scripps (United States) · funded by National Institutes of Health
2021–2022 · research · R01
Chemoproteomic-Enabled Strategy to Study SLC Transporter Roles in Inflammation
Christopher G Parker · Scripps (United States) · funded by National Institutes of Health
2021–2022 · research · R21
Preventing alcohol seeking with a nonmuscle myosin II inhibitor under clinical development
Nicholas Warren Gilpin · Scripps (United States) · funded by National Institutes of Health
2021–2022 · research · R21
Improving AAV-transduction efficiencies for skeletal muscle delivery
Hyeryun Choe · Scripps (United States) · funded by National Institutes of Health
2020–2022 · grant · DP2
Developing next-generation nanodiscs for the study and modulation of membrane proteins
Huan Bao · Scripps (United States) · funded by National Institutes of Health
2020–2022 · research · R01
Molecular and cellular basis for autism spectrum disorders caused by exacerbated translation
Gavin R Rumbaugh · Scripps (United States) · funded by National Institutes of Health
2020–2028 · research · R35
Design of precision small molecules targeting RNA repeating transcripts to manipulate and study disease biology
Matthew D Disney · Scripps (United States) · funded by National Institutes of Health
2020–2023 · fellowship · F31
Neurobiological mechanisms for transient forgetting
John Martin Gabriel Bermeo Sabandal · Scripps (United States) · funded by National Institutes of Health
2020–2021 · research · R56
Elucidating the epigenetic landscape of neurofibromatosis and development of therapeutic targets
Joseph Kissil · Scripps (United States) · funded by National Institutes of Health
2020–2022 · fellowship · F31
Neurobiological mechanisms for transient forgetting
John Martin Gabriel Bermeo Sabandal · Scripps (United States) · funded by National Institutes of Health
2020–2022 · research · R01
Targeted degradation of RNAs by using small molecules
Matthew D Disney · Scripps (United States) · funded by National Institutes of Health
2020–2022 · research · R01
Mechanistic studies of corepressor-mediated PPARγ transcriptional repression
Douglas Kojetin · Scripps (United States) · funded by National Institutes of Health
2020–2022 · fellowship · F31
Developing chemoproteomic approaches to decipher the regulatory network of LRH-1, a nuclear receptor implicated in hepatic metabolism
Valentine Virginie Courouble · Scripps (United States) · funded by National Institutes of Health
2020–2024 · research · R35
Mining Actinomycetal Genomes for Natural Product Discovery and Biosynthesis
Ben Shen · Scripps (United States) · funded by National Institutes of Health
2020–2022 · research · R21
A nonhuman primate model to study the immunological effects of feminizing hormone therapy in transgender women
Mauricio De Aguiar Martins · Scripps (United States) · funded by National Institutes of Health
2020–2022 · cooperative agreement · U19
An AAV-mediated functional cure and its impact on the reservoir
Michael R. Farzan · Scripps (United States) · funded by National Institutes of Health
2020–2022 · research · R35
Dissecting the Mechanisms of Regulation and Quality Control in Ribosome Assembly and the Consequences of their Failure
Katrin Karbstein · Scripps (United States) · funded by National Institutes of Health
2020–2023 · research · R01
Mechanistic studies of corepressor-mediated PPARγ transcriptional repression
Douglas Kojetin · Scripps (United States) · funded by National Institutes of Health
2020–2023 · fellowship · F32
Pharmacological interactions between conventional and biased MOR agonists
Agnes M Acevedo-Canabal · Scripps (United States) · funded by National Institutes of Health
2020–2022 · research · R21
A nonhuman primate model to study the immunological effects of feminizing hormone therapy in transgender women
Mauricio De Aguiar Martins · Scripps (United States) · funded by National Institutes of Health
2020–2022 · research · R21
Eliciting tyrosine-sulfated neutralizing antibodies recognizing the Env apex
Michael R. Farzan · Scripps (United States) · funded by National Institutes of Health
2020–2022 · research · R37
Therapeutic Use of an Enhanced Form of CD4-Ig
Michael R. Farzan · Scripps (United States) · funded by National Institutes of Health
2020–2022 · research · R01
Optimizing eCD4-Ig for eradication and a functional cure
Michael R. Farzan · Scripps (United States) · funded by National Institutes of Health
2020–2022 · research · R01
An injectable hydrogel platform for sustained release of eCD4-Ig
Eric Andrew Appel · Scripps (United States) · funded by National Institutes of Health
